BioCentury | Nov 14, 2020
Emerging Company Profile

Metagenomi hunts for new gene editing systems with $65M series A

...Xetra:BAYN) acquired in 2019. Sozo Ventures, Agent Capital, InCube Ventures...
...Leaps by Bayer, Humboldt Fund, HOF Capital, InCube Ventures...
BioCentury | Mar 8, 2019
Targets & Mechanisms

Oral insulin innovation

...a big problem for cost of goods, he said. Imran is also managing director of InCube Ventures...
...raised over $142 million in venture and private financing from investors and pharmas including GV, InCube Ventures...
BioCentury | May 26, 2017
Financial News

Symic Bio raises $30M in series B

...new investor HEDA Ventures and existing investors Lilly Ventures, Den Danske Forskningsfond, Ally Bridge Group, InCube Ventures...
BioCentury | May 23, 2017
Financial News

Symic Bio raises $30M in series B

...new investor HEDA Ventures and existing investors Lilly Ventures, Den Danske Forskningsfond, Ally Bridge Group, InCube Ventures...
BioCentury | Mar 7, 2016
Financial News

Fe3 Medical completes venture financing

...2016-03-02 Type: Venture financing Raised: $11 million Investors: Jianmin Pharmaceuticals; HG Capital; Ping An Ventures; InCube Ventures WIR...
BioCentury | Feb 29, 2016
Financial News

Rani Therapeutics financial update

...LSE:AZN; NYSE:AZN, London, U.K.); Virtus Inspire Ventures; and Ping An Ventures joined existing investors GV; InCube Ventures...
BioCentury | Feb 25, 2016
Financial News

Delivery play Rani tops off series C

...AstraZeneca plc (LSE:AZN; NYSE:AZN), Virtus Inspire Ventures and Ping An Ventures joined existing investors GV, InCube Ventures...
BioCentury | Dec 7, 2015
Financial News

Symic Biomedical completes venture financing

...Real Estate Equities; Purdue Research Foundation; Den Danske Forskiningsfond; Mitsui Global Investment; Ally Bridge Group; InCube Ventures...
BioCentury | Dec 2, 2015
Financial News

Symic raises $25M in series A-2 round

...also participated, as did existing investors Den Danske Forskningsfond, Mitsui Global Investment, Ally Bridge Group, InCube Ventures...
BioCentury | Jun 29, 2015
Emerging Company Profile

Swallowing large molecules

...None Corporate partners: Novartis AG Number of employees: 25 Funds raised: Over $45 million Investors: InCube Ventures...
Items per page:
1 - 10 of 17
BioCentury | Nov 14, 2020
Emerging Company Profile

Metagenomi hunts for new gene editing systems with $65M series A

...Xetra:BAYN) acquired in 2019. Sozo Ventures, Agent Capital, InCube Ventures...
...Leaps by Bayer, Humboldt Fund, HOF Capital, InCube Ventures...
BioCentury | Mar 8, 2019
Targets & Mechanisms

Oral insulin innovation

...a big problem for cost of goods, he said. Imran is also managing director of InCube Ventures...
...raised over $142 million in venture and private financing from investors and pharmas including GV, InCube Ventures...
BioCentury | May 26, 2017
Financial News

Symic Bio raises $30M in series B

...new investor HEDA Ventures and existing investors Lilly Ventures, Den Danske Forskningsfond, Ally Bridge Group, InCube Ventures...
BioCentury | May 23, 2017
Financial News

Symic Bio raises $30M in series B

...new investor HEDA Ventures and existing investors Lilly Ventures, Den Danske Forskningsfond, Ally Bridge Group, InCube Ventures...
BioCentury | Mar 7, 2016
Financial News

Fe3 Medical completes venture financing

...2016-03-02 Type: Venture financing Raised: $11 million Investors: Jianmin Pharmaceuticals; HG Capital; Ping An Ventures; InCube Ventures WIR...
BioCentury | Feb 29, 2016
Financial News

Rani Therapeutics financial update

...LSE:AZN; NYSE:AZN, London, U.K.); Virtus Inspire Ventures; and Ping An Ventures joined existing investors GV; InCube Ventures...
BioCentury | Feb 25, 2016
Financial News

Delivery play Rani tops off series C

...AstraZeneca plc (LSE:AZN; NYSE:AZN), Virtus Inspire Ventures and Ping An Ventures joined existing investors GV, InCube Ventures...
BioCentury | Dec 7, 2015
Financial News

Symic Biomedical completes venture financing

...Real Estate Equities; Purdue Research Foundation; Den Danske Forskiningsfond; Mitsui Global Investment; Ally Bridge Group; InCube Ventures...
BioCentury | Dec 2, 2015
Financial News

Symic raises $25M in series A-2 round

...also participated, as did existing investors Den Danske Forskningsfond, Mitsui Global Investment, Ally Bridge Group, InCube Ventures...
BioCentury | Jun 29, 2015
Emerging Company Profile

Swallowing large molecules

...None Corporate partners: Novartis AG Number of employees: 25 Funds raised: Over $45 million Investors: InCube Ventures...
Items per page:
1 - 10 of 17